New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme
Glioblastoma multiforme (GBM) is known as the most aggressive and prevalent brain tumor with a high mortality rate. It is reported in people who are as young as 10 years old to as old as over 70 years old, exhibiting inter and intra tumor heterogeneity. There are several genomic and proteomic invest...
Saved in:
Main Authors: | Manisha Singh (Author), Divya Jindal (Author), Vinayak Agarwal (Author), Deepanshi Pathak (Author), Mansi Sharma (Author), Pranav Pancham (Author), Shalini Mani (Author), Rachana (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
by: Harpinder K. Brar, et al.
Published: (2022) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019) -
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
by: Xin Yuan Lim, et al.
Published: (2023) -
Exploring the Therapeutic Effects of Radix Astragalus on Glioblastoma Multiforme Cell Culture
by: Irmak Ferah Okkay, et al.
Published: (2024)